Aldeyra Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| KNOLL CAPITAL MANAGEMENT, LLC | 11/14/2025 | 5.48 M | $28.58 M | 0.00% | 9.12% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 5.22 M | $27.26 M | 28.89% | 8.70% |
| BLACKROCK, INC. | 11/12/2025 | 3.80 M | $19.86 M | -1.22% | 6.34% |
| VANGUARD GROUP INC | 11/07/2025 | 3.59 M | $18.75 M | 2.58% | 5.98% |
| ARDSLEY ADVISORY PARTNERS LP | 11/14/2025 | 1.90 M | $9.92 M | -7.32% | 3.16% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.51 M | $7.86 M | 2.14% | 2.51% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 1.38 M | $7.20 M | 182.94% | 2.30% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 11/14/2025 | 1.33 M | $6.95 M | 0.00% | 2.22% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.18 M | $6.14 M | 2.60% | 1.96% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/13/2025 | 1.11 M | $5.81 M | 61.90% | 1.85% |
| STATE STREET CORP | 11/14/2025 | 1.10 M | $5.76 M | 4.36% | 1.84% |
| MORGAN STANLEY | 11/14/2025 | 1.08 M | $5.65 M | 39.78% | 1.80% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/17/2025 | 947.55 K | $4.95 M | 49.42% | 1.58% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 835.81 K | $4.36 M | 334.41% | 1.39% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 820.00 K | $4.28 M | -24.07% | 1.37% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 648.37 K | $3.38 M | -9.79% | 1.08% |
| NORTHERN TRUST CORP | 11/14/2025 | 407.96 K | $2.13 M | 0.99% | 0.68% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 390.08 K | $2.04 M | 590.51% | 0.65% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 361.47 K | $1.89 M | -0.74% | 0.60% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 314.73 K | $1.64 M | 2.59% | 0.52% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 273.05 K | $1.43 M | 389.88% | 0.45% |
| WOODSTOCK CORP | 10/07/2025 | 266.76 K | $1.39 M | 0.00% | 0.44% |
| JANE STREET GROUP, LLC | 11/14/2025 | 251.52 K | $1.31 M | 160.15% | 0.42% |
| PALO ALTO INVESTORS LP | 11/14/2025 | 225.47 K | $1.18 M | 0.00% | 0.38% |
| UBS GROUP AG | 11/13/2025 | 200.74 K | $1.05 M | 87.16% | 0.33% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 197.30 K | $1.03 M | 74.91% | 0.33% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 189.82 K | $990.87 K | 100.00% | 0.32% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 184.10 K | $961.00 K | 497.73% | 0.31% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 182.94 K | $954.96 K | 31.03% | 0.30% |
| CITADEL ADVISORS LLC | 11/14/2025 | 177.70 K | $927.59 K | 56.15% | 0.30% |
| MARSHALL WACE, LLP | 11/13/2025 | 160.21 K | $836.31 K | 100.00% | 0.27% |
| IEQ CAPITAL, LLC | 11/14/2025 | 159.15 K | $830.78 K | 8.38% | 0.27% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 158.38 K | $826.76 K | -31.66% | 0.26% |
| CITADEL ADVISORS LLC | 11/14/2025 | 152.25 K | $794.77 K | 1,122.53% | 0.25% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 150.48 K | $785.50 K | -4.48% | 0.25% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 149.37 K | $779.69 K | 661.83% | 0.25% |
| NUVEEN, LLC | 11/12/2025 | 144.69 K | $755.26 K | 35.59% | 0.24% |
| SAVANT CAPITAL, LLC | 11/05/2025 | 144.06 K | $752.00 K | -0.03% | 0.24% |
| Y-INTERCEPT (HONG KONG) LTD | 10/31/2025 | 138.09 K | $720.84 K | 100.00% | 0.23% |
| INVESCO LTD. | 11/13/2025 | 133.71 K | $697.94 K | 9.09% | 0.22% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 122.66 K | $640.00 K | 67.35% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 121.85 K | $636.07 K | 9.44% | 0.20% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 113.58 K | $592.91 K | -14.59% | 0.19% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 111.10 K | $579.95 K | 321.74% | 0.19% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 101.38 K | $529.18 K | 238.29% | 0.17% |
| STRS OHIO | 10/30/2025 | 85.70 K | $447.35 K | 4.13% | 0.14% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 81.00 K | $422.82 K | -0.12% | 0.13% |
| RHUMBLINE ADVISERS | 11/06/2025 | 78.65 K | $410.52 K | 1.49% | 0.13% |
| BARCLAYS PLC | 11/12/2025 | 76.64 K | $400.08 K | -19.87% | 0.13% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 75.55 K | $394.37 K | 0.00% | 0.13% |
Aldeyra Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 174 institutional investors and hedge funds held shares of Aldeyra Therapeutics, Inc.. The most heavily invested institutionals were:
Knoll Capital Management, LLC: 5.48 M
PERCEPTIVE ADVISORS LLC: 5.22 M
BlackRock, Inc.: 3.8 M
VANGUARD GROUP INC: 3.59 M
ARDSLEY ADVISORY PARTNERS LP: 1.9 M
AQR CAPITAL MANAGEMENT LLC: 1.51 M
65.46% of Aldeyra Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 44.58 M shares in the last 24 months. This purchase volume represents approximately $255.91 M in transactions.